3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Renal Cell
8
Sarcoma
7
Sarcoma, Clear Cell
2
Neurofibrosarcoma
2
Nerve Sheath Neoplasms
2
Neoplasm Metastasis
2
Liposarcoma
2
Kidney Neoplasms
2
Histiocytoma, Angiomatoid Fibrous
2
Granuloma, Plasma Cell
2
Glioblastoma
2
Fibrosarcoma
2
Dermatofibrosarcoma
2
Chondrosarcoma, Extraskeletal Myxoid
2
Vascular Neoplasms
1
Solitary Fibrous Tumors
1
Solid Neoplasm
1
Smooth Muscle Tumor
1
Sarcoma, Synovial
1
Sarcoma, Alveolar Soft Part
1
Refractory or Recurrent Solid Tumor
1
Perivascular Epithelioid Cell Neoplasms
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Osteosarcoma
1
Neuroendocrine Tumors
1
Neoplasms, Adipose Tissue
1
Myoepithelioma
1
Liposarcoma, Myxoid
1
Leiomyosarcoma
1
Histiocytoma, Malignant Fibrous
1
Interventions
Temozolomide
3
Cyclophosphamide
3
fludarabine phosphate
2
Vincristine
2
PM 01183
2
Irinotecan
2
Ifosfamide
2
Etoposide
2
Doxorubicin
2
thymoglobulin
1
temsirolimus
1
pembrolizumab
1
pegylated granulocyte colony-stimulating factor
1
pegfilgrastim
1
fludarabine
1
Zoledronic Acid
1
Vinorelbine
1
Thiotepa
1
Tacrolimus
1
Surgical Procedures, Operative
1
Stem Cell Transplantation
1
Sorafenib
1
Ramucirumab
1
Radiotherapy, Intensity-Modulated
1
Radiation
1
Proton Therapy
1
Mycophenolic Acid
1
Mesna
1
Melphalan
1
Injections
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Desmoplastic Small Round Cell Tumor
×
pazopanib
×
1 year
×
Clear all
No trials found.